Monoclonal Antibodies: Streamlined Nonclinical Safety Studies: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 2, 2025
December 2, 2025
439cec36-0e7d-4c02-88e4-7a0af7b47fa4
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Malaria: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 23, 2025Center for Drug Evaluation and Research
Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics
Guidance DocumentNovember 15, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox